Skip to main content

Bridging the Gap

We believe that access to innovative medicines can transform outcomes for patients.

Our Research

Our Bridging the Gap work looks at global trends in the development of medicines and access processes. The series of reports set out recommended policy solutions that aim to help create a more accessible pathway to ensure patients can get access to new innovative treatments quicker.

Taking Stock of the UK life sciences environment

This report examines the UK’s evolving life sciences environment and discusses opportunities to further enhance the UK as a life science hub for the benefit of patients, the NHS, and the wider economy, including how the innovative medicines pathway could be strengthened and made fit for the future.

See the full report here

Exploring the evolution of medicine regulatory policy in the UK

Our research identifies trends in the global medicines regulatory environment. In this report we explore policy solutions that could enable the creation of innovative approaches to medicines regulation in the UK which supports early patient access to new, innovative treatments.

See the full report here

Turning innovation into patient care

Drawing on research commissioned by AbbVie, which examined different international technology appraisal systems, this report considers if international approaches could support the acceleration of new and innovative medicines to patients in Scotland.

See the full report here

June 2024